“Estimating the Cost-Effectiveness of Treatment for Prevention of Thromboembolic Events in at-Risk Adults With Non-Valvular Atrial Fibrillation”. Farmeconomia. Health Economics and Therapeutic Pathways 19, no. 1 (February 27, 2018). Accessed February 15, 2026. https://journals.seedstm.com/index.php/FE/article/view/1346.